PT  - JOURNAL ARTICLE
AU  - Amy Attaway
TI  - Management of patients with COPD during the COVID-19 pandemic
AID  - 10.3949/ccjm.87a.ccc007
DP  - 2020 May 11
TA  - Cleveland Clinic Journal of Medicine
PG  - ccc007
4099  - http://www.ccjm.org/content/early/2020/05/06/ccjm.87a.ccc007.short
4100  - http://www.ccjm.org/content/early/2020/05/06/ccjm.87a.ccc007.full
AB  - Patients with COPD have an increased risk for severity of COVID-19. Flu-like symptoms with dyspnea may distinguish COVID-19 infection from dyspnea due to a COPD-related exacerbation. Management of COPD with COVID-19 warrants standard-of-care treatment with antimicrobial agents and corticosteroids, though limiting the dose and duration of steroids use may be warranted due to the risk of increased viral shedding. Modalities to treat acute respiratory failure can be used with some caveats. Patients with COPD and COVID-19 infection who treat their illness at home should self-isolate, use nebulizers in ways that avoid viral aerosolization, and frequently disinfect room surfaces.